Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (January 5th, 2019)

Scott Willis·January 5, 2019

2019 will see only 25 retail stores in Ontario. Germany delays cultivation licenses again, A list of US...

Aphria Subsidiary Developing Medical Cannabis Curriculum in Colombia

Ty Arthur·January 3, 2019

Aphria subsidiary Colcanna SAS is developing curriculum for medical students and doctors on the use of cannabis in...

Scott Willis·December 28, 2018

The hostile bid for Aphria has put consumer goods companies on notice. Invest now or lose out on...

Ty Arthur·December 21, 2018

Continuing to expand outside the company’s home base of Canada, Aphria Inc. will soon cultivate medical grade marijuana...

Editor·December 17, 2018

In this episode of All Time Highs, Thomas George discusses the Farm Bill opening the door to CBD...

Scott Willis·December 8, 2018

Aphria worth closer to $10/sh than $0/sh. Altria investment was a decent deal for the company, New US...

Ty Arthur·December 8, 2018

Aphria's board of directors announced the appointment of an independent committee to review the company’s September acquisition of...

Editor·December 6, 2018

In this episode of All Time Highs, Thomas George discusses the merits of the recent short report from...

Scott Willis·December 6, 2018

Cronos is running low on cash and without an Altria deal in sight, the company need to break-even...

Username
Password

	Remember Me Lost your password?